J&J comments on Pfizer Consumer Healthcare

17 October 2017 - Deborah Wilkes

Archived

Johnson & Johnson has commented on Pfizer's recent announcement that it is considering a range of strategic alternatives, including divestment, for its global Consumer Healthcare business.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: